Skip to main content

Table 2 Data of muscle biopsy with dystrophin staining, deletion detected by multiplex PCR, reading frame, and eligibility to exon skipping therapy

From: The analysis of DMD gene deletions by multiplex PCR in Indonesian DMD/BMD patients: the era of personalized medicine

ID no

Dystrophin staining

Exons deletions

Reading frame

Amenability to exon skipping

1

Absence

12, 17, 44

Out of frame

N/A

2

N/A

3–17, 44

Out of frame

N/A

3

N/A

3–17, 44

Out of frame

N/A

4

N/A

8–17

Out of frame

N/A

5

N/A

45–52

Out of frame

Exon 53 skip-amenable

6

Absence

45–52

Out of frame

Exon 53 skip-amenable

7

N/A (HE only)

46–50

Out of frame

N/A

8

N/A (HE only)

46–50

Out of frame

N/A

9

Partly

46–51

Out of frame

Exon 45 skip-amenable

10

Absence

48–50

Out of frame

Exon 51 skip-amenable

11

Partly

50–51

In frame

N/A

12

N/A (HE only)

50

Out of frame

Exon 51 skip-amenable

13

N/A

50

Out of frame

Exon 53 skip-amenable

14

Absence

50–52

Out of frame

Exon 53 skip-amenable

15

Absence

52

Out of frame

Exon 51 skip-amenable